| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |